Scientists at USC Michelson Center for Convergent Bioscience and Japan’s Nagoya University find and test a promising drug that stops cancer by interfering with the cancer cells’ metabolism and other circadian-related functions
A new drug shows potential to halt cancer cells’ growth by stunting the cells’ biological clock.
The findings from scientists at the USC Michelson Center for Convergent Bioscience and Nagoya University’s Institute of Transformative BioMolecules (ITbM) advance a burgeoning area of research: turning the body’s circadian rhythms against cancer.
Their study, conducted on human kidney cancer cells and on acute myeloid leukemia in mice, was published Jan. 23 in the journal Science Advances.
Scientists know that disrupting sleep and other elements of humans’ circadian rhythm can harm health. The same is true for the circadian clock of cells themselves. If researchers could disturb the circadian clock of cancer cells, they theorize, they could potentially hurt or kill those cells.
The scientists found that a molecule named GO289 targets an enzyme that controls the cell’s circadian rhythm. This drug-protein interaction then disrupts the functions of four other proteins that are important for cell growth and survival.
Human bone cancer cells stopped growing when a drug molecule jammed their circadian rhythm during a study that appears in Science Advances. Photo courtesy of the Kay lab at the USC Michelson Center for Convergent Bioscience.
In effect, GO289 can jam the cogs of the cell’s circadian clock, slowing its cycles. And it can do so with little impact to healthy cells.
“In some cancers, the disease takes over the circadian clock mechanism and uses it for the evil purpose of helping itself grow,” said Steve Kay, director of convergent biosciences at the USC Michelson Center and USC Provost Professor of Neurology, Biomedical Engineering and Biological Sciences. “With GO289, we can interfere with those processes and stop the cancer from growing.”
Kay is among several scientists from USC Dornsife College of Letters, Arts and Sciences, USC Viterbi School of Engineering and Keck School of Medicine of USC who are collaborating across multiple disciplines to find new solutions for treating cancer, neurological disease and cardiovascular disease.
Finding the right candidate
On its initial interactions with human bone cancer cells, GO289 appeared to slow the tumors’ circadian clock as it targeted an enzyme, named CK2.
To see if GO289 consistently hindered other cancers in the same way, the scientists then tested it on human kidney cancer cells and on mice with acute myeloid leukemia. They found that GO289 specifically affected cancer cell metabolism and other circadian-related functions that normally would enable the cancer to grow and spread.
Kay is optimistic about the findings. “This could become an effective new weapon that kills cancer,” he said.
Learn more: Cancer has a biological clock and this drug may keep it from ticking
The Latest on: Cancer
[google_news title=”” keyword=”cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer
- This is how we do it: ‘Since having prostate cancer I can’t get an erection, but I still get just as much pleasure’on April 27, 2024 at 3:01 am
With penetrative sex no longer an option, Sebastian and Teresa have found different ways to satisfy one other
- Harry Jowsey Issues Summer Warning After ‘Doctors Found Skin Cancer’ On Himon April 26, 2024 at 10:03 pm
"If you're freckly little frog like me, go get a mole map and get your body checked because you never know," said the TV personality
- Rush, MD Anderson announce new cancer center partnershipon April 26, 2024 at 6:16 pm
MD Anderson is known for having the world's largest cancer clinical trials program, so the partnership with Rush means thousand will have access to more and better treatment options.
- With new partnership, Rush Copley in Aurora aims to become ‘destination cancer program in the western suburbs’on April 26, 2024 at 4:26 pm
New partnership announced between the Rush University System for Health and The University of Texas MD Anderson Cancer Center.
- Air monitor for ‘Cancer Alley’ community expected to be operational soonon April 26, 2024 at 10:45 am
Community activists in St. James Parish had raised concerns over what they said was a delay in installing the monitor.
- Medicare Refusing to Pay for Cancer Scan Sparks Warning for Patientson April 26, 2024 at 8:39 am
When it comes to breast cancer screening, women are often told they need an additional scan beyond just a mammogram because these scans can miss tumors in women with dense breast tissue. However, Medicare has routinely refused to cover the lifesaving ultrasound and MRI scans that the doctors order, The New York Times reported last week.
- ‘Real hope’ for cancer cure as personal mRNA vaccine for melanoma trialledon April 26, 2024 at 3:07 am
Excitement among patients and researchers as custom-built jabs enter phase 3 trial
via Bing News